TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Metastatic Colorectal Cancer Surgery Market Research Report 2023

Global Metastatic Colorectal Cancer Surgery Market Research Report 2023

  • Category:Life Sciences
  • Published on : 13 December 2022
  • Pages :89
  • Formats:
  • Report Code:SMR-7507287
OfferClick for best price

Best Price: $2320

Metastatic Colorectal Cancer Surgery Market Size, Share 2022


Market Analysis and Insights: Global Metastatic Colorectal Cancer Surgery Market

The global Metastatic Colorectal Cancer Surgery market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metastatic Colorectal Cancer Surgery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metastatic Colorectal Cancer Surgery market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metastatic Colorectal Cancer Surgery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metastatic Colorectal Cancer Surgery market.

Global Metastatic Colorectal Cancer Surgery Scope and Market Size

Market Analysis and Insights: Global Metastatic Colorectal Cancer Surgery Market

Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body parts i.e. metastatic colorectal cancers are difficult to treat and have 11%-12% 5-year relative survival rate.

The global Metastatic Colorectal Cancer Surgery market size is projected to reach US$ million by 2030, from US$ million in 2022, at a CAGR of % during 2023-2030.

Treatment of metastatic colorectal cancer is multidisciplinary field involving early evaluation for resection of hepatic metastasis, metastasectomy and coordinated chemotherapy or radiation therapy. Primary factors driving growth of metastatic colorectal cancer treatment market are increasing prevalence of colorectal cancer across the globe, rapid innovation in personalized medicine and discovery of new targets for treatment of colorectal cancers.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metastatic Colorectal Cancer Surgery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metastatic Colorectal Cancer Surgery market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metastatic Colorectal Cancer Surgery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metastatic Colorectal Cancer Surgery market.

Global Metastatic Colorectal Cancer Surgery Scope and Market Size

Metastatic Colorectal Cancer Surgery market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Metastatic Colorectal Cancer Surgery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2030.

Segment by Type

Tumor Resection

Portal Vein Embolization

Segment by Application

Hospitals

Clinics

Cancer Research Centers

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Sanofi

Roche

Eli Lilly

Pfizer

Novartis

Amgen

Taiho Oncology

Genentech

EMD Serono

Suzhou Zelgen Biopharmaceuticals

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Metastatic Colorectal Cancer Surgery product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Metastatic Colorectal Cancer Surgery, with price, sales, revenue, and global market share of Metastatic Colorectal Cancer Surgery from 2019 to 2022.

Chapter 3, the Metastatic Colorectal Cancer Surgery competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Metastatic Colorectal Cancer Surgery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Metastatic Colorectal Cancer Surgery market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Metastatic Colorectal Cancer Surgery.

Chapter 13, 14, and 15, to describe Metastatic Colorectal Cancer Surgery sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Metastatic Colorectal Cancer Surgery Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Metastatic Colorectal Cancer Surgery Market Research Report 2023
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 89 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastatic Colorectal Cancer Surgery Market Size Growth Rate by Type: 2017 VS 2022 VS 2030
1.2.2 Tumor Resection
1.2.3 Portal Vein Embolization
1.3 Market by Application
1.3.1 Global Metastatic Colorectal Cancer Surgery Market Share by Application: 2017 VS 2022 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Research Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Metastatic Colorectal Cancer Surgery Market Perspective (2017-2030)
2.2 Metastatic Colorectal Cancer Surgery Growth Trends by Region
2.2.1 Metastatic Colorectal Cancer Surgery Market Size by Region: 2017 VS 2022 VS 2030
2.2.2 Metastatic Colorectal Cancer Surgery Historic Market Size by Region (2017-2023)
2.2.3 Metastatic Colorectal Cancer Surgery Forecasted Market Size by Region (2023-2030)
2.3 Metastatic Colorectal Cancer Surgery Market Dynamics
2.3.1 Metastatic Colorectal Cancer Surgery Industry Trends
2.3.2 Metastatic Colorectal Cancer Surgery Market Drivers
2.3.3 Metastatic Colorectal Cancer Surgery Market Challenges
2.3.4 Metastatic Colorectal Cancer Surgery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metastatic Colorectal Cancer Surgery Players by Revenue
3.1.1 Global Top Metastatic Colorectal Cancer Surgery Players by Revenue (2017-2023)
3.1.2 Global Metastatic Colorectal Cancer Surgery Revenue Market Share by Players (2017-2023)
3.2 Global Metastatic Colorectal Cancer Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metastatic Colorectal Cancer Surgery Revenue
3.4 Global Metastatic Colorectal Cancer Surgery Market Concentration Ratio
3.4.1 Global Metastatic Colorectal Cancer Surgery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastatic Colorectal Cancer Surgery Revenue in 2022
3.5 Metastatic Colorectal Cancer Surgery Key Players Head office and Area Served
3.6 Key Players Metastatic Colorectal Cancer Surgery Product Solution and Service
3.7 Date of Enter into Metastatic Colorectal Cancer Surgery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metastatic Colorectal Cancer Surgery Breakdown Data by Type
4.1 Global Metastatic Colorectal Cancer Surgery Historic Market Size by Type (2017-2023)
4.2 Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Type (2023-2030)
5 Metastatic Colorectal Cancer Surgery Breakdown Data by Application
5.1 Global Metastatic Colorectal Cancer Surgery Historic Market Size by Application (2017-2023)
5.2 Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Metastatic Colorectal Cancer Surgery Market Size (2017-2030)
6.2 North America Metastatic Colorectal Cancer Surgery Market Size by Country (2017-2023)
6.3 North America Metastatic Colorectal Cancer Surgery Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Metastatic Colorectal Cancer Surgery Market Size (2017-2030)
7.2 Europe Metastatic Colorectal Cancer Surgery Market Size by Country (2017-2023)
7.3 Europe Metastatic Colorectal Cancer Surgery Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size (2017-2030)
8.2 Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size by Country (2017-2023)
8.3 Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Metastatic Colorectal Cancer Surgery Market Size (2017-2030)
9.2 Latin America Metastatic Colorectal Cancer Surgery Market Size by Country (2017-2023)
9.3 Latin America Metastatic Colorectal Cancer Surgery Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size (2017-2030)
10.2 Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size by Country (2017-2023)
10.3 Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Metastatic Colorectal Cancer Surgery Introduction
11.1.4 Sanofi Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023)
11.1.5 Sanofi Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Metastatic Colorectal Cancer Surgery Introduction
11.2.4 Roche Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023)
11.2.5 Roche Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Metastatic Colorectal Cancer Surgery Introduction
11.3.4 Eli Lilly Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023)
11.3.5 Eli Lilly Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Metastatic Colorectal Cancer Surgery Introduction
11.4.4 Pfizer Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023)
11.4.5 Pfizer Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Metastatic Colorectal Cancer Surgery Introduction
11.5.4 Novartis Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023)
11.5.5 Novartis Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Metastatic Colorectal Cancer Surgery Introduction
11.6.4 Amgen Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023)
11.6.5 Amgen Recent Development
11.7 Taiho Oncology
11.7.1 Taiho Oncology Company Detail
11.7.2 Taiho Oncology Business Overview
11.7.3 Taiho Oncology Metastatic Colorectal Cancer Surgery Introduction
11.7.4 Taiho Oncology Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023)
11.7.5 Taiho Oncology Recent Development
11.8 Genentech
11.8.1 Genentech Company Detail
11.8.2 Genentech Business Overview
11.8.3 Genentech Metastatic Colorectal Cancer Surgery Introduction
11.8.4 Genentech Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023)
11.8.5 Genentech Recent Development
11.9 EMD Serono
11.9.1 EMD Serono Company Detail
11.9.2 EMD Serono Business Overview
11.9.3 EMD Serono Metastatic Colorectal Cancer Surgery Introduction
11.9.4 EMD Serono Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023)
11.9.5 EMD Serono Recent Development
11.10 Suzhou Zelgen Biopharmaceuticals
11.10.1 Suzhou Zelgen Biopharmaceuticals Company Detail
11.10.2 Suzhou Zelgen Biopharmaceuticals Business Overview
11.10.3 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Surgery Introduction
11.10.4 Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023)
11.10.5 Suzhou Zelgen Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Metastatic Colorectal Cancer Surgery Market Size Growth Rate by Type (US$ Million): 2017 VS 2022 VS 2030
Table 2. Key Players of Tumor Resection
Table 3. Key Players of Portal Vein Embolization
Table 4. Global Metastatic Colorectal Cancer Surgery Market Size Growth by Application (US$ Million): 2017 VS 2022 VS 2030
Table 5. Global Metastatic Colorectal Cancer Surgery Market Size by Region (US$ Million): 2017 VS 2022 VS 2030
Table 6. Global Metastatic Colorectal Cancer Surgery Market Size by Region (2017-2023) & (US$ Million)
Table 7. Global Metastatic Colorectal Cancer Surgery Market Share by Region (2017-2023)
Table 8. Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Region (2023-2030) & (US$ Million)
Table 9. Global Metastatic Colorectal Cancer Surgery Market Share by Region (2023-2030)
Table 10. Metastatic Colorectal Cancer Surgery Market Trends
Table 11. Metastatic Colorectal Cancer Surgery Market Drivers
Table 12. Metastatic Colorectal Cancer Surgery Market Challenges
Table 13. Metastatic Colorectal Cancer Surgery Market Restraints
Table 14. Global Metastatic Colorectal Cancer Surgery Revenue by Players (2017-2023) & (US$ Million)
Table 15. Global Metastatic Colorectal Cancer Surgery Market Share by Players (2017-2023)
Table 16. Global Top Metastatic Colorectal Cancer Surgery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Colorectal Cancer Surgery as of 2022)
Table 17. Ranking of Global Top Metastatic Colorectal Cancer Surgery Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Metastatic Colorectal Cancer Surgery Revenue (CR5 and HHI) & (2017-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Metastatic Colorectal Cancer Surgery Product Solution and Service
Table 21. Date of Enter into Metastatic Colorectal Cancer Surgery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Metastatic Colorectal Cancer Surgery Market Size by Type (2017-2023) & (US$ Million)
Table 24. Global Metastatic Colorectal Cancer Surgery Revenue Market Share by Type (2017-2023)
Table 25. Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Type (2023-2030) & (US$ Million)
Table 26. Global Metastatic Colorectal Cancer Surgery Revenue Market Share by Type (2023-2030)
Table 27. Global Metastatic Colorectal Cancer Surgery Market Size by Application (2017-2023) & (US$ Million)
Table 28. Global Metastatic Colorectal Cancer Surgery Revenue Market Share by Application (2017-2023)
Table 29. Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Application (2023-2030) & (US$ Million)
Table 30. Global Metastatic Colorectal Cancer Surgery Revenue Market Share by Application (2023-2030)
Table 31. North America Metastatic Colorectal Cancer Surgery Market Size by Country (2017-2023) & (US$ Million)
Table 32. North America Metastatic Colorectal Cancer Surgery Market Size by Country (2023-2030) & (US$ Million)
Table 33. Europe Metastatic Colorectal Cancer Surgery Market Size by Country (2017-2023) & (US$ Million)
Table 34. Europe Metastatic Colorectal Cancer Surgery Market Size by Country (2023-2030) & (US$ Million)
Table 35. Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size by Region (2017-2023) & (US$ Million)
Table 36. Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size by Region (2023-2030) & (US$ Million)
Table 37. Latin America Metastatic Colorectal Cancer Surgery Market Size by Country (2017-2023) & (US$ Million)
Table 38. Latin America Metastatic Colorectal Cancer Surgery Market Size by Country (2023-2030) & (US$ Million)
Table 39. Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size by Country (2017-2023) & (US$ Million)
Table 40. Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size by Country (2023-2030) & (US$ Million)
Table 41. Sanofi Company Detail
Table 42. Sanofi Business Overview
Table 43. Sanofi Metastatic Colorectal Cancer Surgery Product
Table 44. Sanofi Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023) & (US$ Million)
Table 45. Sanofi Recent Development
Table 46. Roche Company Detail
Table 47. Roche Business Overview
Table 48. Roche Metastatic Colorectal Cancer Surgery Product
Table 49. Roche Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Eli Lilly Company Detail
Table 52. Eli Lilly Business Overview
Table 53. Eli Lilly Metastatic Colorectal Cancer Surgery Product
Table 54. Eli Lilly Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023) & (US$ Million)
Table 55. Eli Lilly Recent Development
Table 56. Pfizer Company Detail
Table 57. Pfizer Business Overview
Table 58. Pfizer Metastatic Colorectal Cancer Surgery Product
Table 59. Pfizer Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. Novartis Company Detail
Table 62. Novartis Business Overview
Table 63. Novartis Metastatic Colorectal Cancer Surgery Product
Table 64. Novartis Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Amgen Company Detail
Table 67. Amgen Business Overview
Table 68. Amgen Metastatic Colorectal Cancer Surgery Product
Table 69. Amgen Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023) & (US$ Million)
Table 70. Amgen Recent Development
Table 71. Taiho Oncology Company Detail
Table 72. Taiho Oncology Business Overview
Table 73. Taiho Oncology Metastatic Colorectal Cancer Surgery Product
Table 74. Taiho Oncology Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023) & (US$ Million)
Table 75. Taiho Oncology Recent Development
Table 76. Genentech Company Detail
Table 77. Genentech Business Overview
Table 78. Genentech Metastatic Colorectal Cancer Surgery Product
Table 79. Genentech Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023) & (US$ Million)
Table 80. Genentech Recent Development
Table 81. EMD Serono Company Detail
Table 82. EMD Serono Business Overview
Table 83. EMD Serono Metastatic Colorectal Cancer Surgery Product
Table 84. EMD Serono Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023) & (US$ Million)
Table 85. EMD Serono Recent Development
Table 86. Suzhou Zelgen Biopharmaceuticals Company Detail
Table 87. Suzhou Zelgen Biopharmaceuticals Business Overview
Table 88. Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Surgery Product
Table 89. Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Surgery Business (2017-2023) & (US$ Million)
Table 90. Suzhou Zelgen Biopharmaceuticals Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Colorectal Cancer Surgery Market Share by Type: 2022 VS 2030
Figure 2. Tumor Resection Features
Figure 3. Portal Vein Embolization Features
Figure 4. Global Metastatic Colorectal Cancer Surgery Market Share by Application in 2022 & 2030
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Cancer Research Centers Case Studies
Figure 8. Metastatic Colorectal Cancer Surgery Report Years Considered
Figure 9. Global Metastatic Colorectal Cancer Surgery Market Size (US$ Million), Year-over-Year: 2017-2030
Figure 10. Global Metastatic Colorectal Cancer Surgery Market Size, (US$ Million), 2017 VS 2022 VS 2030
Figure 11. Global Metastatic Colorectal Cancer Surgery Market Share by Region: 2022 VS 2030
Figure 12. Global Metastatic Colorectal Cancer Surgery Market Share by Players in 2022
Figure 13. Global Top Metastatic Colorectal Cancer Surgery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Colorectal Cancer Surgery as of 2022)
Figure 14. The Top 10 and 5 Players Market Share by Metastatic Colorectal Cancer Surgery Revenue in 2022
Figure 15. North America Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 16. North America Metastatic Colorectal Cancer Surgery Market Share by Country (2017-2030)
Figure 17. United States Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 18. Canada Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 19. Europe Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 20. Europe Metastatic Colorectal Cancer Surgery Market Share by Country (2017-2030)
Figure 21. Germany Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 22. France Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 23. U.K. Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 24. Italy Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 25. Russia Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 26. Nordic Countries Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 27. Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 28. Asia-Pacific Metastatic Colorectal Cancer Surgery Market Share by Region (2017-2030)
Figure 29. China Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 30. Japan Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 31. South Korea Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 32. Southeast Asia Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 33. India Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 34. Australia Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 35. Latin America Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 36. Latin America Metastatic Colorectal Cancer Surgery Market Share by Country (2017-2030)
Figure 37. Mexico Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 38. Brazil Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 39. Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 40. Middle East & Africa Metastatic Colorectal Cancer Surgery Market Share by Country (2017-2030)
Figure 41. Turkey Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 42. Saudi Arabia Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 43. Sanofi Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2017-2023)
Figure 44. Roche Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2017-2023)
Figure 45. Eli Lilly Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2017-2023)
Figure 46. Pfizer Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2017-2023)
Figure 47. Novartis Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2017-2023)
Figure 48. Amgen Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2017-2023)
Figure 49. Taiho Oncology Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2017-2023)
Figure 50. Genentech Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2017-2023)
Figure 51. EMD Serono Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2017-2023)
Figure 52. Suzhou Zelgen Biopharmaceuticals Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2017-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount